Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SPARTALIZUMAB vs SPIRONOLACTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SPARTALIZUMAB vs SPIRONOLACTONE: Safety Overview

Metric SPARTALIZUMAB SPIRONOLACTONE
Total FAERS Reports 288 21,052
Deaths Reported 23 1,809
Death Rate 8.0% 8.6%
Hospitalizations 235 11,611
Average Patient Age 61.1 yrs 66.1 yrs
% Female Patients 59.2% 55.1%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A REMEDYREPACK INC.
Route N/A ORAL
Marketing Status N/A Prescription